Want to see STAA full AI Analyst Report?
Total Valuation
Staar Surgical has a market cap or net worth of $1.32B. The enterprise value is $902.09.
Market Cap$1.32B
Enterprise Value$902.09
Share Statistics
Staar Surgical has 49,788,494 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,788,494
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Staar Surgical’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -11.26%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.17
Return on Invested Capital (ROIC)-11.26%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee206.95K
Profits Per Employee-69.53K
Employee Count1,157
Asset Turnover0.52
Inventory Turnover1.03
Valuation Ratios
The current PE Ratio of Staar Surgical is ―. Staar Surgical’s PEG ratio is -0.05.
PE Ratio―
PS Ratio4.89
PB Ratio3.40
Price to Fair Value3.40
Price to FCF-29.21
Price to Operating Cash Flow-26.29
PEG Ratio-0.05
Income Statement
In the last 12 months, Staar Surgical had revenue of 239.44M and earned -80.45M in profits. Earnings per share was -1.62.
Revenue239.44M
Gross Profit182.42M
Operating Income-45.95M
Pretax Income-82.26M
Net Income-80.45M
EBITDA-73.53M
Earnings Per Share (EPS)-1.62
Cash Flow
In the last 12 months, operating cash flow was -50.19M and capital expenditures -4.79M, giving a free cash flow of -54.99M billion.
Operating Cash Flow-50.19M
Free Cash Flow-54.99M
Free Cash Flow per Share-1.10
Dividends & Yields
Staar Surgical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.06
52-Week Price Change48.87%
50-Day Moving Average29.27
200-Day Moving Average24.49
Relative Strength Index (RSI)40.46
Average Volume (3m)662.76K
Important Dates
Staar Surgical upcoming earnings date is Aug 12, 2026, After Close (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Staar Surgical as a current ratio of 4.55, with Debt / Equity ratio of 10.58%
Current Ratio4.55
Quick Ratio3.74
Debt to Market Cap0.00
Net Debt to EBITDA1.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Staar Surgical has paid -1.81M in taxes.
Income Tax-1.81M
Effective Tax Rate0.02
Enterprise Valuation
Staar Surgical EV to EBITDA ratio is -14.35, with an EV/FCF ratio of -26.34.
EV to Sales4.41
EV to EBITDA-14.35
EV to Free Cash Flow-26.34
EV to Operating Cash Flow-30.82
Balance Sheet
Staar Surgical has $163.89M in cash and marketable securities with $37.29M in debt, giving a net cash position of $126.60M billion.
Cash & Marketable Securities$163.89M
Total Debt$37.29M
Net Cash$126.60M
Net Cash Per Share$2.54
Tangible Book Value Per Share$6.29
Margins
Gross margin is 76.43%, with operating margin of -19.19%, and net profit margin of -33.60%.
Gross Margin76.43%
Operating Margin-19.19%
Pretax Margin-34.36%
Net Profit Margin-33.60%
EBITDA Margin-30.71%
EBIT Margin-34.36%
Analyst Forecast
The average price target for Staar Surgical is $32.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$32.60
Price Target Upside29.98% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast4.03%
EPS Growth Forecast70.55%